Kok Pin Ng1,2,3, Tharick A Pascoal1,2, Sulantha Mathotaarachchi1,2, Yiong Huak Chan4, Lai Jiang5,6, Joseph Therriault1,2, Andrea L Benedet1,2, Monica Shin1,2, Nagaendran Kandiah3, Celia M T Greenwood5,6, Pedro Rosa-Neto1,2, Serge Gauthier7,8. 1. Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, McGill University, Montréal, Québec, Canada. 2. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Montreal, Canada. 3. Department of Neurology, National Neuroscience Institute, Singapore City, Singapore. 4. Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore. 5. Lady Davis Institute, McGill University, Montreal, Canada. 6. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. 7. Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, McGill University, Montréal, Québec, Canada. serge.gauthier@mcgill.ca. 8. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Montreal, Canada. serge.gauthier@mcgill.ca.
Abstract
BACKGROUND: Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer's disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carriers are young individuals who are destined to develop AD in future due to the full penetrance of the genetic mutation. Hence, the study of DIAD mutation carriers enables the evaluation of the associations between pure AD pathophysiology and metabolic correlates of NPS without the confounding effects of co-existing pathologies. In this longitudinal study, we aimed to identify regional brain metabolic dysfunctions associated with NPS in cognitively intact DIAD mutation carriers. METHODS: We stratified 221 cognitively intact participants from the Dominantly Inherited Alzheimer's Network according to their mutation carrier status. The interactions of NPS measured by the Neuropsychiatric Inventory-Questionnaire (NPI-Q), age, and estimated years to symptom onset (EYO) as a function of metabolism measured by [18F]flurodeoxyglucose ([18F]FDG) positron emission tomography, were evaluated by the mixed-effects regression model with family-level random effects in DIAD mutation carriers and non-carriers. Exploratory factor analysis was performed to identify the neuropsychiatric subsyndromes in DIAD mutation carriers using the NPI-Q sub-components. Then the effects of interactions between specific neuropsychiatric subsyndromes and EYO on metabolism were evaluated with the mixed-effects regression model. RESULTS: A total of 119 mutation carriers and 102 non-carriers were studied. The interaction of higher NPI-Q and shorter EYO was associated with more rapid declines of global and regional [18F]FDG uptake in the posterior cingulate and ventromedial prefrontal cortices, the bilateral parietal lobes and the right insula in DIAD mutation carriers. The neuropsychiatric subsyndromes of agitation, disinhibition, irritability and depression interacted with the EYO to drive the [18F]FDG uptake decline in the DIAD mutation carriers. The interaction of NPI and EYO was not associated with [18F]FDG uptake in DIAD mutation non-carriers. CONCLUSIONS: The NPS in cognitively intact DIAD mutation carriers may be a clinical indicator of subsequent metabolic decline in brain networks vulnerable to AD, which supports the emerging conceptual framework that NPS represent early manifestations of neuronal injury in AD. Further studies using different methodological approaches to identify NPS in preclinical AD are needed to validate our findings.
BACKGROUND: Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer's disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carriers are young individuals who are destined to develop AD in future due to the full penetrance of the genetic mutation. Hence, the study of DIAD mutation carriers enables the evaluation of the associations between pure AD pathophysiology and metabolic correlates of NPS without the confounding effects of co-existing pathologies. In this longitudinal study, we aimed to identify regional brain metabolic dysfunctions associated with NPS in cognitively intact DIAD mutation carriers. METHODS: We stratified 221 cognitively intact participants from the Dominantly Inherited Alzheimer's Network according to their mutation carrier status. The interactions of NPS measured by the Neuropsychiatric Inventory-Questionnaire (NPI-Q), age, and estimated years to symptom onset (EYO) as a function of metabolism measured by [18F]flurodeoxyglucose ([18F]FDG) positron emission tomography, were evaluated by the mixed-effects regression model with family-level random effects in DIAD mutation carriers and non-carriers. Exploratory factor analysis was performed to identify the neuropsychiatric subsyndromes in DIAD mutation carriers using the NPI-Q sub-components. Then the effects of interactions between specific neuropsychiatric subsyndromes and EYO on metabolism were evaluated with the mixed-effects regression model. RESULTS: A total of 119 mutation carriers and 102 non-carriers were studied. The interaction of higher NPI-Q and shorter EYO was associated with more rapid declines of global and regional [18F]FDG uptake in the posterior cingulate and ventromedial prefrontal cortices, the bilateral parietal lobes and the right insula in DIAD mutation carriers. The neuropsychiatric subsyndromes of agitation, disinhibition, irritability and depression interacted with the EYO to drive the [18F]FDG uptake decline in the DIAD mutation carriers. The interaction of NPI and EYO was not associated with [18F]FDG uptake in DIAD mutation non-carriers. CONCLUSIONS: The NPS in cognitively intact DIAD mutation carriers may be a clinical indicator of subsequent metabolic decline in brain networks vulnerable to AD, which supports the emerging conceptual framework that NPS represent early manifestations of neuronal injury in AD. Further studies using different methodological approaches to identify NPS in preclinical AD are needed to validate our findings.
Authors: Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2015-06-18 Impact factor: 21.566
Authors: Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani Journal: Hum Brain Mapp Date: 2016-07-13 Impact factor: 5.038
Authors: Kristiina Karttunen; Pertti Karppi; Asta Hiltunen; Matti Vanhanen; Tarja Välimäki; Janne Martikainen; Hannu Valtonen; Juhani Sivenius; Hilkka Soininen; Sirpa Hartikainen; Jaana Suhonen; Tuula Pirttilä Journal: Int J Geriatr Psychiatry Date: 2010-10-29 Impact factor: 3.485
Authors: Diego Alfonso López Mora; Frederic Sampedro; Valle Camacho; Alejandro Fernández; Francisco Fuentes; Joan Duch; Jesús Pérez-Perez; Saül Martínez-Horta; Juan Marín-Lahoz; Anna Domènech; Albert Flotats; Montserrat Estorch; Jaime Kulisevsky; Ignasi Carrió Journal: Clin Nucl Med Date: 2019-01 Impact factor: 7.794
Authors: John M Ringman; Sarah Monsell; Denise W Ng; Yan Zhou; Andy Nguyen; Giovanni Coppola; Victoria Van Berlo; Mario F Mendez; Spencer Tung; Sandra Weintraub; Marek-Marsel Mesulam; Eileen H Bigio; Darren R Gitelman; Amanda O Fisher-Hubbard; Roger L Albin; Harry V Vinters Journal: J Neuropathol Exp Neurol Date: 2016-02-17 Impact factor: 3.685
Authors: Kristoffer H Hellton; Jeffrey Cummings; Audun Osland Vik-Mo; Jan Erik Nordrehaug; Dag Aarsland; Geir Selbaek; Lasse Melvaer Giil Journal: Multivariate Behav Res Date: 2020-04-24 Impact factor: 5.923
Authors: Eric R Braverman; Catherine A Dennen; Mark S Gold; Abdalla Bowirrat; Ashim Gupta; David Baron; A Kenison Roy; David E Smith; Jean Lud Cadet; Kenneth Blum Journal: Int J Environ Res Public Health Date: 2022-04-30 Impact factor: 4.614